Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 50090-1528

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 50090-1528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chmical Structure (Chlordiazepoxide 01)

Chemical structure diagram of chlordiazepoxide hydrochloride showing its molecular arrangement, including a chlorinated benzene ring and diazepine ring system.*

FDA Label Image

Chmical Structure (Chlordiazepoxide 02)

Chemical structure of the active ingredient shown, depicting a bromide-substituted nitrogen-containing ring connected to a bicyclic phenyl group with hydroxyl and ester functional groups, consistent with clidinium bromide's molecular structure.*

FDA Label Image

Label Image (Lbl500901528)

Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules, 5 mg/2.5 mg strength, packaged with 30 capsules per container. The label shows the product name, strength, dosage form, and storage instructions (store at 77 degrees F). The product is packaged and labeled by A-S Medication Solutions in Libertyville, Illinois, including relevant NDC and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.